Confirmed

One controlled phase 3 trial met its main goal, and satralizumab is approved for this use.

Trial timeline

Phase 2/320172017
Phase 320142014

Trial start year. Dot size reflects participants where reported. Only trials that count towards the status are shown.

NMOSD · IL-6 pathway

Two or more controlled phase 3 trials met their main goal, or one did and a medicine of this approach is approved for this use.

Trials
6
Running now
1
Controlled phase 2/3 trials
3
People in controlled trials
298

Deciding trials (phase 3): 1 met, 0 did not.

Other linked trials: 5

Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.

Trials

Other linked trials: 5

These linked trials do not set the status.

The deciding phase and counts come from the Trial Bank’s fixed rules.

Lab evidence

Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.

Loading lab studies…

Loading reviews and guidelines…

History

  • 2026-10-28Status changed from Being tested to Confirmed
  • 2026-10-27First listed as Being tested

Related hypotheses

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error